Business Description
Sanofi India Ltd
ISIN : INE058A01010
Share Class Description:
BOM:500674: Ordinary SharesTotal Employee Number:
1,104Compare
Compare
Traded in other countries / regions
500674.India IPO Date
1991-03-01Description
Sanofi India Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It focuses on a range of therapeutic areas, including diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines, among others, and sells its products through independent distributors predominantly in India. The company's products are manufactured in different types of dosage forms, including tablets, capsules (hard and soft), Eye/Ear drops, ampoules, vials, creams, and ointments, and are marketed under different brand names such as Soframycin, Lantus, Cardace, Soliqua, Solian, Thyrogen, Telcite, Zolineg, etc. Geographically, the company generates a majority of its revenue from India, followed by Singapore, and Other markets.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 14.77 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.04 | |||||
Interest Coverage | 250.29 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 12.44 | |||||
Beneish M-Score | -3.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.6 | |||||
3-Year EBITDA Growth Rate | -18.9 | |||||
3-Year EPS without NRI Growth Rate | -13.2 | |||||
3-Year FCF Growth Rate | 3.1 | |||||
3-Year Book Growth Rate | -16.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.92 | |||||
9-Day RSI | 38.71 | |||||
14-Day RSI | 43.85 | |||||
3-1 Month Momentum % | -0.05 | |||||
6-1 Month Momentum % | -15.22 | |||||
12-1 Month Momentum % | -41.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1 | |||||
Cash Ratio | 0.54 | |||||
Days Inventory | 147.9 | |||||
Days Sales Outstanding | 38.97 | |||||
Days Payable | 101.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.7 | |||||
Dividend Payout Ratio | 1.34 | |||||
3-Year Dividend Growth Rate | 2 | |||||
Forward Dividend Yield % | 7.23 | |||||
5-Year Yield-on-Cost % | 6.38 | |||||
Shareholder Yield % | 3.65 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 49.77 | |||||
Operating Margin % | 23.99 | |||||
Net Margin % | 17.47 | |||||
EBITDA Margin % | 25.69 | |||||
FCF Margin % | 23.26 | |||||
OCF Margin % | 24.71 | |||||
ROE % | 38.86 | |||||
ROA % | 22.64 | |||||
ROIC % | 41.58 | |||||
3-Year ROIIC % | 150.68 | |||||
ROC (Joel Greenblatt) % | 110.97 | |||||
ROCE % | 51.19 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.1 | |||||
Forward PE Ratio | 19.61 | |||||
PE Ratio without NRI | 23.55 | |||||
Shiller PE Ratio | 13.08 | |||||
Price-to-Owner-Earnings | 19.08 | |||||
PS Ratio | 4.39 | |||||
PB Ratio | 10.38 | |||||
Price-to-Tangible-Book | 10.22 | |||||
Price-to-Free-Cash-Flow | 18.85 | |||||
Price-to-Operating-Cash-Flow | 17.73 | |||||
EV-to-EBIT | 17.67 | |||||
EV-to-EBITDA | 16.24 | |||||
EV-to-Revenue | 4.18 | |||||
EV-to-FCF | 18.32 | |||||
Price-to-GF-Value | 0.75 | |||||
Price-to-Projected-FCF | 1.71 | |||||
Price-to-Median-PS-Value | 1.37 | |||||
Price-to-Graham-Number | 3.16 | |||||
| Price-to-Net-Current-Asset-Value | 25.93 | |||||
Earnings Yield (Greenblatt) % | 5.65 | |||||
FCF Yield % | 5.4 | |||||
Forward Rate of Return (Yacktman) % | -9.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sanofi India Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 17,738 | ||
| EPS (TTM) (₹) | 134.51 | ||
| Beta | 1.3132 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.29 | ||
| Volatility % | 28.48 | ||
| 14-Day RSI | 43.85 | ||
| 14-Day ATR (₹) | 67.05705 | ||
| 20-Day SMA (₹) | 3388.035 | ||
| 12-1 Month Momentum % | -41.64 | ||
| 52-Week Range (₹) | 3057.6 - 5780.75 | ||
| Shares Outstanding (Mil) | 23.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sanofi India Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sanofi India Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 16:30 | In 89 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 88 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 16:00 | In 4 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 3 days | ||
| General meeting for 2025 | 2026-04-29 15:30 | 3,469.00 (+1.62%) | ||
| First quarter earnings results for 2026 | 2026-04-28 | 3,433.05 (+0.23%) | ||
| INR 48.000000 Cash Dividend | 2026-04-22 | 3,587.20 (+0.70%) | ||
| Annual report for 2025 | 2026-04-02 | 3,262.60 (-0.26%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 16:00 | 4,138.75 (+0.94%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 4,138.75 (+0.94%) |
Show
Entries
Sanofi India Ltd Frequently Asked Questions
What is Sanofi India Ltd(BOM:500674)'s stock price today?
The current price of BOM:500674 is ₹3321.00. The 52 week high of BOM:500674 is ₹5780.75 and 52 week low is ₹3057.60.
When is next earnings date of Sanofi India Ltd(BOM:500674)?
The next earnings date of Sanofi India Ltd(BOM:500674) is 2026-08-05.
Does Sanofi India Ltd(BOM:500674) pay dividends? If so, how much?
The Dividend Yield %  of Sanofi India Ltd(BOM:500674) is 3.7% (As of Today), Highest Dividend Payout Ratio of Sanofi India Ltd(BOM:500674) was 1.34. The lowest was 0.33. And the median was 0.49. The  Forward Dividend Yield % of Sanofi India Ltd(BOM:500674) is 7.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sanofi India Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers